VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo
Bladder cancer (BC) is one of the most common malignant tumors in the urinary system with growing morbidity and diagnostic rate in recent years. Therefore, identifying new molecular biomarkers that inhibit the progression of bladder cancer is needed for developing further therapeutics. This study fo...
Saved in:
Main Authors: | Jiacheng Wu (Author), Tao Li (Author), Hao Ji (Author), Zhi Chen (Author), Baoqian Zhai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of VRK1 as a Novel Potential Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
by: He X, et al.
Published: (2024) -
Axonal Neuropathy, Microcephaly and VRK1 Mutations
by: J Gordon Millichap, et al.
Published: (2014) -
Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer
by: Qi Lin, et al.
Published: (2019) -
G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo
by: Kun Zhu, et al.
Published: (2022) -
Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis
by: Chi-yi Jiang, et al.
Published: (2021)